Singapore Bio-Innovations
investment firm
About
Singapore Bio-Innovations is a venture capital firm that finances later stage investments.
- Singapore,Central Region,Singapore
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
6
1
Singapore Bio-Innovations has made 6 investments. Their most recent investment was on
Dec 22, 2008, when Humanigen raised $12M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 22, 2008
Humanigen
|
Series D | $12M | Biopharma | — |
|
Sep 23, 2008
Humanigen
|
Series D | $20M | Biopharma | — |
|
Aug 3, 2007
Humanigen
|
Series C | $20M | Biopharma | Yes |
|
Mar 16, 2005
Humanigen
|
Series B | $20M | Biopharma | — |
|
Feb 8, 2005
Five Prime Therapeutics
|
Series Unknown | $45M | Biotechnology | — |
Exits
Singapore Bio-Innovations has had 3 exits. Singapore Bio-Innovations most notable exits include Humanigen , Five Prime Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Aug 7, 2017 | Humanigen | IPO | Biopharma | Detail |
| Sep 18, 2013 | Five Prime Therapeutics | M&A | Biotechnology | Detail |
| Jul 15, 2005 | Aderis Pharmaceuticals | M&A | Biopharma | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
